Abstract
Background Radiofrequency-assisted liposuction involves the delivery of a controlled amount of energy to treated tissue resulting in fat liquefaction, accompanying hemostasis, and skin tightening. The purpose of this study is to report experience with a larger sample size using the BodyTiteTM radiofrequency-assisted liposuction (RFAL) platform, and its first use with local tumescent anesthesia. The BodyTiteTM device is currently awaiting FDA approval.
